HOUSTON, Jan. 31, 2022 /PRNewswire/ -- KBR (NYSE: KBR) was selected to continue providing high-end astronaut medical support services for the European Space Agency's (ESA's) European Astronaut Centre (EAC) Space Medicine Office in Cologne, Germany.
Under the terms of the recompete contract, KBR will be the primary provider of space medicine support services to ESA, which is introducing a new service model. This work is scheduled to be performed over a three-and-a-half-year period.
A partner to ESA for more than 20 years, KBR's major activities include astronaut medical care, engineering support, rehabilitation, fitness, project management, healthcare administration, psychology and behavioral health, nutrition, radiation, education coordination, and operational research.
"Every opportunity to work with ESA and our coordinating commercial and government space partners adds to the future of space exploration while highlighting its many positive beand globalizing our space expertise," said Byron Bright, KBR Government Solutions President.
Throughout KBR's many years of support to ESA, it has aided more than 15 launch and landing campaigns in Russia and Kazakhstan, as well as 20 missions to the ISS in a variety of visiting vehicles. KBR's partnership has also influenced millions in research funding for space medicine operations and led to the establishment of the ESA Space Health International Network for Exploration (SHINE).
KBR is known for its expertise in the space and medical fields having worked directly with NASA and the U.S. government on several life science research studies and human health and performance contracts for decades.
We deliver science, technology and engineering solutions to governments and companies around the world. KBR employs approximately 29,000 people worldwide with customers in more than 80 countries and operations in 40 countries.
KBR is proud to work with its customers across the globe to provide technology, value-added services, and long- term operations and maintenance services to ensure consistent delivery with predictable results. At KBR, We Deliver.
Forward Looking Statement
The statements in this press release that are not historical statements, including statements regarding future financial performance, are forward-looking statements within the meaning of the federal securities laws. These statements are subject to numerous risks and uncertainties, many of which are beyond the company's control that could cause actual results to differ materially from the results expressed or implied by the statements. These risks and uncertainties include, but are not limited to: the significant adverse impacts on economic and market conditions of the COVID-19 pandemic and the company's ability to respond to the resulting challenges and business disruption; the recent dislocation of the global energy market; the company's ability to manage its liquidity; the outcome of and the publicity surrounding audits and investigations by domestic and foreign government agencies and legislative bodies; potential adverse proceedings by such agencies and potential adverse results and consequences from such proceedings; changes in capital spending by the company's customers; the company's ability to obtain contracts from existing and new customers and perform under those contracts; structural changes in the industries in which the company operates; escalating costs associated with and the performance of fixed-fee projects and the company's ability to control its cost under its contracts; claims negotiations and contract disputes with the company's customers; changes in the demand for or price of oil and/or natural gas; protection of intellectual property rights; compliance with environmental laws; changes in government regulations and regulatory requirements; compliance with laws related to income taxes; unsettled political conditions, war and the effects of terrorism; foreign operations and foreign exchange rates and controls; the development and installation of financial systems; the possibility of cyber and malware attacks; increased competition for employees; the ability to successfully complete and integrate acquisitions; and operations of joint ventures, including joint ventures that are not controlled by the company.
The company's most recently filed Annual Report on Form 10-K, any subsequent Form 10-Qs and 8-Ks, and other U.S. Securities and Exchange Commission filings discuss some of the important risk factors that the company has identified that may affect its business, results of operations and financial condition. Except as required by law, the company undertakes no obligation to revise or update publicly any forward-looking statements for any reason.
View original content to download multimedia:https://www.prnewswire.com/news-releases/kbr-selected-as-primary-provider-of-space-medicine-support-to-european-space-agency-301471225.html
SOURCE KBR, Inc.